Disease-specific overall survival in endometrioid ovarian
Por um escritor misterioso
Descrição
PARP Inhibitors for Ovarian Cancer: Current Indications, Future Combinations, and Novel Assets in Development to Target DNA Damage Repair
Endometriosis in clear cell and endometrioid carcinoma ovary: its impact on clinicopathological characteristics and survival outcomes - ecancer
Ovarian clear cell carcinoma with or without endometriosis origin in a single institution cohort
Patient-initiated follow-up after treatment for low risk endometrial cancer: a prospective audit of outcomes and cost benefits
Diagnostics, Free Full-Text
Diagnostics, Free Full-Text
Develop a nomogram to predict overall survival of patients with borderline ovarian tumors
Ovarian Cancer Survival Rate
Treatment of Early Stage High-Risk Endometrioid-Type Endometrial Cancer and Patterns of Disease Relapse: A Retrospective Analysis - Advances in Radiation Oncology
Clinical factors associated with prognosis in low-grade serous ovarian carcinoma: experiences at two large academic institutions in Korea and Taiwan
Could HIPEC Hold Promise for Advanced Endometrial Cancer? – Consult QD
Ovarian Epithelial, Fallopian, & Peritoneal Cancer Treatment (PDQ®) - NCI
Synchronous endometrial and ovarian cancer: A case report
Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study - The Lancet Oncology
Analysis of recurrence and survival rates in grade 3 endometrioid endometrial carcinoma
de
por adulto (o preço varia de acordo com o tamanho do grupo)
